Synthetic biology startup StrainX Bioworks secured $13 million (₹124 crore) in funding led by PrimeVP and Leo Capital.
The company uses advanced precision fermentation to engineer microbes and sustainably manufacture commercial food ingredients.
The fresh capital will be heavily deployed toward expanding physical fermentation capacity and accelerating global commercialization efforts.
This investment signals a major shift in the Indian startup ecosystem, proving domestic venture capital is increasingly backing high-CapEx deep tech and bio-manufacturing.
Read the full story on StartupFox